Home

Helen Torley, President and CEO: Halozyme Therapeutics HALO Sell · Filed 25/07/10

Trade details

Type
Insider sale
Amount
$1,116,862.56
Shares · price
19,792 sh · $56.43 a share
Held after
733,927 sh
Trade date
25/07/09
Filed
25/07/10
Days to filing
1 days

Sold 2.6% of holdings

Share of holding sold
2.6%

Halozyme Therapeutics trades, last 26 weeks

What else happened in Halozyme Therapeutics around then

Filed or reported within 30 days of the trade day · 25/06/09~25/08/08

Helen Torley's recent trades

  • Helen Torley

    Planned sale10b5-1 planHalozyme Therapeutics

    $23.7M

    Filed 08/17

  • Helen Torley

    Sell10b5-1 planHalozyme Therapeutics

    $1.1M

    Filed 06/03

  • Helen Torley

    Sell10b5-1 planHalozyme Therapeutics

    $875.6K

    Filed 06/03

  • Helen Torley

    Sell10b5-1 planHalozyme Therapeutics

    $425.1K

    Filed 06/03

  • Helen Torley

    Sell10b5-1 planHalozyme Therapeutics

    $369.2K

    Filed 06/03

Helen Torley, CEO — sold $1.1M of Halozyme Therapeutics HALO · 2.6% of holdings · 10b5-1 plan | Whalegun